May 29, 2019 | Portfolio News

Intact Vascular, Vesper Medical Raise Capital to Tackle Blood-Vessel Diseases

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A